All articles tagged with #glp 1 therapies
The WHO has issued its first guidelines on GLP-1 medications for obesity, emphasizing that these drugs should be part of a comprehensive approach including lifestyle changes, and highlighting the need for increased global access and long-term care strategies. While effective, GLP-1 therapies are not a cure-all and should be used with caution, especially considering their rising popularity and social implications.
The World Health Organization has issued its first guideline on using GLP-1 medicines to treat obesity, emphasizing that these therapies can support long-term management of obesity alongside lifestyle changes, but should be part of a comprehensive approach. The guideline highlights the importance of equitable access, health system readiness, and multisectoral strategies to address the global obesity crisis, which affects over 1 billion people and causes millions of deaths annually.
Weight loss medications, such as the popular GLP-1 therapies, are proving to be effective tools for patients struggling with obesity, with some achieving significant weight loss comparable to bariatric surgery. However, these medications come with lifelong commitments and high costs, with Medicare not covering anti-obesity drugs. While these medications show promise in curbing hunger and cravings, they also come with potential side effects and are not a one-size-fits-all solution. Despite the challenges, patients like Niki Hernandez and her mother Faith Baran are finding success with these medications, highlighting the ongoing struggle and need for effective long-term solutions in managing obesity.